Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence
Vodusek, Ana Lina, Goricar, Katja, Gazic, Barbara, Dolzan, Vita, Jazbec, Janez
The influence of folate pathway polymorphisms on high-dose methotrexaterelated toxicity and survival in children with non-Hodgkin malignant lymphoma
Erculj, Nina, Kotnik, Barbara Faganel, Debeljak, Marusa, Jazbec, Janez, Dolzan, Vita
The association of genetic factors with serum calretinin levels in asbestos-related diseases
Zupanc, Cita, Franko, Alenka, Strbac, Danijela, Kovac, Viljem, Dolzan, Vita, Goricar, Katja
Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases
Goricar, Katja, Kovac, Viljem, Dodic-Fikfak, Metoda, Dolzan, Vita, Franko, Alenka
Association of OPRM1, MIR23B, and MIR107 genetic variability with acute pain, chronic pain and adverse effects after postoperative tramadol and paracetamol treatment in breast cancer
Vidic, Zala, Goricar, Katja, Strazisar, Branka, Besic, Nikola, Dolzan, Vita
Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage
Goricar, Katja, Erculj, Nina, Zadel, Maja, Dolzan, Vita
Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma
Goricar, Katja, Kovac, Viljem, Dolzan, Vita
Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases
Mervic, Ana, Goricar, Katja, Blagus, Tanja, Franko, Alenka, Trebusak-Podkrajsek, Katarina, Fikfak, Metoda Dodic, Dolzan, Vita, Kovac, Viljem
The role of polymorphisms in glutathione-related genes in asbestos-related diseases
Franko, Alenka, Goricar, Katja, Dodic Fikfak, Metoda, Kovac, Viljem, Dolzan, Vita
The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma
Piber, Petra, Vavpetic, Neza, Goricar, Katja, Dolzan, Vita, Kovac, Viljem, Franko, Alenka
Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma
Setina, Matic, Setina, Eva, Doljak, Ziga, Goricar, Katja, Dolzan, Vita, Kovac, Viljem